Polysialylated asparaginase: preparation, activity and pharmacokinetics (Q73705903)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Polysialylated asparaginase: preparation, activity and pharmacokinetics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

G Gregoriadis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

Biochimica et Biophysica Acta

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

1341

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

26-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

L-asparaginase and PEG asparaginase--past, present, and future

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

A phase II trial of PEG-L-asparaginase in the treatment of non-Hodgkins lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

l-Asparaginase resistance in human leukemia—Asparagine synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Two L-asparaginases from E. coli and their action against tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Suppression of murine leukemias by L-asparaginase. Incidence of sensitivity among leukemias of various types: comparative inhibitory activities of guinea pig serum L-asparaginase and Escherichia coli L-asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Tumour regression with liposome-entrapped asparaginase: some immunological advantages

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

L-Asparaginase entrapped in liposomes: Preparation and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Artificial cells in medicine and biotechnology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

The in vivo Effects of Semipermeable Microcapsules containing L-Asparaginase on 6C3HED Lymphosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Erythrocytes as carriers for L-asparaginase. Methodological and mouse in-vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

A new chemotherapeutic agent: L-asparaginase entrapped in red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Soluble asparaginase-dextran conjugates show increased circulatory persistence and lowered antigen reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Chemical modification of enzyme molecules to improve their characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Antitumor enzyme: polyethylene glycol-modified asparaginase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Liposomal palmitoyl-L-asparaginase: characterization and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Modification of E. coli L-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serum

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Polysialic acids: potential in drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Synthesis, characterization and properties of sialylated catalase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

The effect of chemical modification of L-asparaginase on its persistence in circulating blood of animals

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Reductive alkylation of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Cyanohydridoborate anion as a selective reducing agent

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Metabolism of protein anticancer agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

Catabolism of therapeutic proteins and peptides with implications for drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900056-3

7 January 2021

10.1016/S0167-4838(97)00056-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9300806%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference